Retinoic acid therapy resistance progresses from unilineage to bilineage in HL-60 leukemic blasts.
Jensen, Holly A
Retinoic acid therapy resistance progresses from unilineage to bilineage in HL-60 leukemic blasts. [electronic resource] - PloS one 2014 - e98929 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1932-6203
10.1371/journal.pone.0098929 doi
Antigens, CD--genetics
Antineoplastic Agents--pharmacology
Cell Differentiation
Cell Line, Tumor
G1 Phase Cell Cycle Checkpoints
Granulocyte Precursor Cells--cytology
Humans
Tretinoin--pharmacology
Retinoic acid therapy resistance progresses from unilineage to bilineage in HL-60 leukemic blasts. [electronic resource] - PloS one 2014 - e98929 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1932-6203
10.1371/journal.pone.0098929 doi
Antigens, CD--genetics
Antineoplastic Agents--pharmacology
Cell Differentiation
Cell Line, Tumor
G1 Phase Cell Cycle Checkpoints
Granulocyte Precursor Cells--cytology
Humans
Tretinoin--pharmacology